Setting the Course
Guest Post by Matthew J. Sikora, PhD University of Pittsburgh Cancer Institute
Category: Meetings
Guest Post by Matthew J. Sikora, PhD University of Pittsburgh Cancer Institute
Advances against cancer that make it to the clinic are a result of many years of hard work by...
The rapid fire of U.S. Food and Drug Administration (FDA) approvals of new treatments for cancer continued last week...
When the hottest minds in cancer genomics meet the hottest minds in computational and systems biology, you can rest...
Guest Post by Anees B. Chagpar, MD, MPH, MBA Yale Cancer Center
Adding the PI3-kinase inhibitor pictilisib to fulvestrant doubled progression-free survival for some women with advanced hormone-receptor positive breast cancer,...
After making great strides for some patients with melanoma and lung cancer, immunotherapy drugs are starting to offer hope...
SABCS co-chair and AACR President Carlos L. Arteaga, MD, shares his views on this year's symposium and what the...
Guest Post by T.J. Sharpe Originally appeared on Philly.com's Patient #1 blog
Nina Bhardwaj, MD, PhD, co-chair of the AACR's special conference "Tumor Immunology and Immunotherapy: A New Chapter," discusses what...